DK0462305T3 - Anvendelse af cytokinholdige aerosoler såvel som cytokholdige aerosoler i sig selv - Google Patents

Anvendelse af cytokinholdige aerosoler såvel som cytokholdige aerosoler i sig selv

Info

Publication number
DK0462305T3
DK0462305T3 DK90111717.6T DK90111717T DK0462305T3 DK 0462305 T3 DK0462305 T3 DK 0462305T3 DK 90111717 T DK90111717 T DK 90111717T DK 0462305 T3 DK0462305 T3 DK 0462305T3
Authority
DK
Denmark
Prior art keywords
cytokine
containing aerosols
well
per
oncoses
Prior art date
Application number
DK90111717.6T
Other languages
English (en)
Inventor
Edith Dr Huland
Hartwig Prof Dr Huland
Original Assignee
Huland Edith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huland Edith filed Critical Huland Edith
Application granted granted Critical
Publication of DK0462305T3 publication Critical patent/DK0462305T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
DK90111717.6T 1990-06-21 1990-06-21 Anvendelse af cytokinholdige aerosoler såvel som cytokholdige aerosoler i sig selv DK0462305T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90111717A EP0462305B1 (de) 1990-06-21 1990-06-21 Verwendung zytokinhaltiger Aerosole und zytokinhaltige Aerosole selbst

Publications (1)

Publication Number Publication Date
DK0462305T3 true DK0462305T3 (da) 1995-04-24

Family

ID=8204117

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90111717.6T DK0462305T3 (da) 1990-06-21 1990-06-21 Anvendelse af cytokinholdige aerosoler såvel som cytokholdige aerosoler i sig selv

Country Status (8)

Country Link
US (1) US5399341A (da)
EP (1) EP0462305B1 (da)
JP (1) JPH04230222A (da)
AT (1) ATE113469T1 (da)
CA (1) CA2043992A1 (da)
DE (1) DE59007645D1 (da)
DK (1) DK0462305T3 (da)
ES (1) ES2065434T3 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE262330T1 (de) * 1997-05-27 2004-04-15 Us Gov Health & Human Serv Verwendung eines nitroxids oder seiner prodrugs zur prophylaktischen und therapeutischen behandlung von krebs
NZ520379A (en) * 1999-12-30 2004-05-28 Chiron Corp Methods for administrering interleukin-2 by pulmonary inhalation
US20030072717A1 (en) * 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
DE60213228T2 (de) * 2001-05-21 2007-06-21 Injet Digital Aerosols Ltd., North Ryde Zusammensetzungen für die freisetzung von protein auf dem pulmonalen weg
WO2011029931A1 (en) * 2009-09-11 2011-03-17 Protaffin Biotechnologie Ag Composition for treatment of cxcl8-mediated lung inflammation
US9028808B2 (en) 2010-01-28 2015-05-12 Immunservice Gmbh Methods for treating nicotine addiction and reducing food consumption
CN102462837B (zh) * 2010-11-19 2016-08-03 生物林格斯Ip有限公司 抗炎组合物
WO2013075719A1 (en) 2011-11-23 2013-05-30 Flsmidth A/S Method and plant for manufacturing cement clinker

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
JPS62207226A (ja) * 1986-03-07 1987-09-11 Sumitomo Pharmaceut Co Ltd 経鼻投与用製剤
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
ES2032831T5 (es) * 1986-08-19 2001-02-16 Genentech Inc Dispositivo y dispersion para suministro intrapulmonar de factores de crecimiento polipeptidos y citoquinas.
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
JPH02124832A (ja) * 1988-07-08 1990-05-14 Toray Ind Inc インターヘェロンβ組成物
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5011678A (en) * 1989-02-01 1991-04-30 California Biotechnology Inc. Composition and method for administration of pharmaceutically active substances

Also Published As

Publication number Publication date
JPH04230222A (ja) 1992-08-19
DE59007645D1 (de) 1994-12-08
ES2065434T3 (es) 1995-02-16
EP0462305A1 (de) 1991-12-27
CA2043992A1 (en) 1991-12-22
US5399341A (en) 1995-03-21
ATE113469T1 (de) 1994-11-15
EP0462305B1 (de) 1994-11-02

Similar Documents

Publication Publication Date Title
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
ATE427124T1 (de) Heiss-geschmolzene extrudierbare pharmazeutische formulierung
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
FI862011A0 (fi) Terapeutiska nukleosider.
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
DK0971717T3 (da) Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
FI963277A0 (fi) Paramuunisuusinduktori, joka perustuu rokkoviruskomponenttien yhdistelmiin, menetelmä sen valmistamiseksi ja sen käyttö lääkeaineena
ATE100098T1 (de) Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
DK0462305T3 (da) Anvendelse af cytokinholdige aerosoler såvel som cytokholdige aerosoler i sig selv
DK0551077T3 (da) Anvendelse af humant atrialt natriuretisk peptid til fremstilling af farmaceutiske præparater til behandling af akut lungeb
FI950290A7 (fi) Uusia bioaktiivisia koostumuksia, niiden valmistus ja käyttö
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
FI102169B (fi) 3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lää keaineina
IT1240683B (it) Composizione farmaceutica contenente egf
DE68900760D1 (de) Virushemmende nukleosidmischung.
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI900724A7 (fi) Anesteettisia, oraalisia koostumuksia
ES2126580T3 (es) Proteina condromodulina-ii.
TW228524B (da)
EP0536311A4 (en) Compositions comprising vitamin d precursors, analogs thereof and their use
IT1243358B (it) Composizioni farmaceutiche per la somministrazione orale di irudina
SE9602262D0 (sv) New use of derivatives of cystine
DE69208913D1 (de) 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung